-+ 0.00%
-+ 0.00%
-+ 0.00%

Catalyst Pharmaceuticals Announces Topline Results From Two-Part Phase 1 Clinical Study Of Vamorolone In Healthy Adult Volunteers

Benzinga·06/30/2026 12:09:09
Listen to the news

The study demonstrated balanced corticosteroid activity with expected cortisol suppression and no evidence of significant immunosuppressive activity at clinical doses.